Related Experiment Videos
Treatment of hypernephroma with xenogeneic immune RNA
National Cancer Institute Monograph
|December 1, 1978
Abstract:
The treatment of patients with hypernephroma with xenogeneic immune RNA was discussed. The toxicity from xenogeneic immune RNA therapy was minimal in patients receiving simple doses from 4 to 64 mg intracutaneously and with cumulative doses of 450 mg during a 30-month period.